Brain Tumors Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Tumors, including details on symptoms, benign and malignant tumors, gliomas, screening, treatment.

Volume 6 (2009), Issue 8 (August)

1. Endoscopic, image-guided, transnasal instillation of (32)P for recurrent infrachiasmatic cystic craniopharyngioma.
   Minim Invasive Neurosurg, 52(3): 137-40. [Abstract] [Full-text]
2. Extended endoscopic endonasal approach to the skull base.
   Minim Invasive Neurosurg, 52(3): 114-8. [Abstract] [Full-text]
3. Gliomas of the cingulate gyrus: surgical management and functional outcome.
   Neurosurg Focus, 27(2): E9. [Abstract] [Full-text]
4. Functional outcome after language mapping for insular World Health Organization Grade II gliomas in the dominant hemisphere: experience with 24 patients.
   Neurosurg Focus, 27(2): E7. [Abstract] [Full-text]
5. Chronic epilepsy associated with temporal tumors: long-term surgical outcome.
   Neurosurg Focus, 27(2): E6. [Abstract] [Full-text]
6. Brain tumors in the mesial temporal lobe: long-term oncological outcome.
   Neurosurg Focus, 27(2): E5. [Abstract] [Full-text]
7. Tumor-associated epilepsy.
   Neurosurg Focus, 27(2): E4. [Abstract] [Full-text]
8. Surgical anatomy and functional connectivity of the limbic system.
   Neurosurg Focus, 27(2): E3. [Abstract] [Full-text]
9. Embryological development of the human insula and its implications for the spread and resection of insular gliomas.
   Neurosurg Focus, 27(2): E2. [Abstract] [Full-text]
10. Endoscopic disconnection of hypothalamic astrocytoma causing gelastic epilepsy. Case report.
    J Neurosurg Pediatr, 4(2): 151-5. [Abstract] [Full-text]
11. Hypothalamic lipoma associated with severe obesity. Report of 2 cases.
    J Neurosurg Pediatr, 4(2): 147-50. [Abstract] [Full-text]
12. Hemiparkinsonism due to a pontomesencephalic cavernoma: improvement after resection. Case report.
    J Neurosurg Pediatr, 4(2): 143-6. [Abstract] [Full-text]
13. Mixed germ cell tumor of the midbrain. Case Report.
    J Neurosurg Pediatr, 4(2): 137-42. [Abstract] [Full-text]
14. Symptomatic intracystic hemorrhage in pineal cysts. Report of 3 cases.
    J Neurosurg Pediatr, 4(2): 130-6. [Abstract] [Full-text]
15. Surgical treatment of ectopic recurrence of craniopharyngioma. Report of 4 cases.
    J Neurosurg Pediatr, 4(2): 105-12. [Abstract] [Full-text]
16. Role of Rac1-regulated signaling in medulloblastoma invasion. Laboratory investigation.
    J Neurosurg Pediatr, 4(2): 97-104. [Abstract] [Full-text]
17. Retrospective analysis of treatment outcome in 315 patients with oligodendroglial brain tumors.
    BMC Neurol, 9: 33. [Abstract] [Full-text]
18. Hydrogel matrix entrapping PLGA-paclitaxel microspheres: drug delivery with near zero-order release and implantability advantages for malignant brain tumour chemotherapy.
    Pharm Res, 26(9): 2101-14. [Abstract] [Full-text]
19. Prognostic factors for survival and intracerebral control after irradiation for brain metastases from gynecological cancer.
    Gynecol Oncol, 114(3): 506-8. [Abstract] [Full-text]
20. Sniffing out cancer using the JPL electronic nose: a pilot study of a novel approach to detection and differentiation of brain cancer.
    Neuroimage, 47: T5-9. [Abstract] [Full-text]
21. Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas. Clinical article.
    J Neurosurg, 111(2): 282-92. [Abstract] [Full-text]
22. Infrared thermal imaging: a review of the literature and case report.
    Neuroimage, 47: T154-62. [Abstract] [Full-text]
23. Effect of trans sodium crocetinate on brain tumor oxygenation. Laboratory investigation.
    J Neurosurg, 111(2): 226-9. [Abstract] [Full-text]
24. NCI-sponsored trial for the evaluation of safety and preliminary efficacy of 3'-deoxy-3'-[18F]fluorothymidine (FLT) as a marker of proliferation in patients with recurrent gliomas: preliminary efficacy studies.
    Mol Imaging Biol, 11(5): 343-55. [Abstract] [Full-text]
25. Magnetic resonance imaging for preoperative identification of the lenticulostriate arteries in insular glioma surgery. Technical note.
    J Neurosurg, 111(2): 278-81. [Abstract] [Full-text]
26. Low-grade oligodendroglioma: an indolent but incurable disease? Clinical article.
    J Neurosurg, 111(2): 265-71. [Abstract] [Full-text]
27. Osler vindicated: glioma of the leg center with Jacksonian epilepsy; removal and cure, with a 50-year follow-up. Historical vignette.
    J Neurosurg, 111(2): 293-300. [Abstract] [Full-text]
28. Risk factors for postoperative systemic complications in elderly patients with brain tumors. Clinical article.
    J Neurosurg, 111(2): 258-64. [Abstract] [Full-text]
29. Computerized assessment of vessel morphological changes during treatment of glioblastoma multiforme: report of a case imaged serially by MRA over four years.
    Neuroimage, 47: T143-51. [Abstract] [Full-text]
30. Comparison of blocked and event-related fMRI designs for pre-surgical language mapping.
    Neuroimage, 47: T107-15. [Abstract] [Full-text]
31. Gender differences in facial expression recognition in survivors of pediatric brain tumors.
    Psychooncology, 18(8): 893-7. [Abstract] [Full-text]
32. Cytoplasmic LRIG2 expression is associated with poor oligodendroglioma patient survival.
    Neuropathology, 29(3): 242-7. [Abstract] [Full-text]
33. 18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.
    Eur J Radiol, 71(2): 242-8. [Abstract] [Full-text]
34. Perioperative high-dose-rate brachytherapy in the treatment of recurrent malignant gliomas.
    Strahlenther Onkol, 185(8): 524-9. [Abstract] [Full-text]
35. Detection of human herpesvirus-6 variants in pediatric brain tumors: association of viral antigen in low grade gliomas.
    J Clin Virol, 46(1): 37-42. [Abstract] [Full-text]
36. Spontaneous immortalization of oligodendroglial cells derived from an SV40 T antigen-positive human glioblastoma multiforme.
    Cancer Lett, 283(2): 212-21. [Abstract] [Full-text]
37. Clinical analysis of patients who survived for less than 3 months after brain metastatectomy.
    J Korean Med Sci, 24(4): 641-8. [Abstract] [Full-text]
38. How powerful is CD133 as a cancer stem cell marker in brain tumors?
    Cancer Treat Rev, 35(5): 403-8. [Abstract] [Full-text]
39. Unusual leptomeningeal dissemination in a child with extracranial metastatic alveolar rhabdomyosarcoma.
    Pediatr Hematol Oncol, 26(6): 473-8. [Abstract] [Full-text]
40. Agraphia after awake surgery for brain tumor: new insights into the anatomo-functional network of writing.
    Surg Neurol, 72(3): 223-41; discussion 241. [Abstract] [Full-text]
41. Advances in the genetics of glioblastoma: are we reaching critical mass?
    Nat Rev Neurol, 5(8): 419-26. [Abstract] [Full-text]
42. Disinhibition of sequential actions following right frontal lobe damage.
    Cogn Neuropsychol, 26(3): 266-85. [Abstract] [Full-text]
43. Orthostatic hypotension associated with an epidermoid tumor of the IV ventricle.
    J Neurol, 256(8): 1357-9. [Abstract] [Full-text]
44. Glioma vascularity correlates with reduced patient survival and increased malignancy.
    Surg Neurol, 72(3): 242-6; discussion 246-7. [Abstract] [Full-text]
45. Cell phones and brain tumors: a review including the long-term epidemiologic data.
    Surg Neurol, 72(3): 205-14; discussion 214-5. [Abstract] [Full-text]
46. There are no estrogen and progesterone receptors in cerebral cavernomas: a preliminary immunohistochemical study.
    Surg Neurol, 72(3): 263-5; discussion 265. [Abstract] [Full-text]
47. Stereotactic radiosurgery for pituitary metastases.
    Surg Neurol, 72(3): 248-55; discussion 255-6. [Abstract] [Full-text]
48. Hemangiopericytoma of the cerebellopontine angle: a case report and review of the literature.
    Surg Neurol, 72(3): 290-5. [Abstract] [Full-text]
49. Understanding the origins of gliomas and developing novel therapies: cerebrospinal fluid and subventricular zone interplay.
    Semin Oncol, 36(4): S17-24. [Abstract] [Full-text]
50. Targeting MAPK (Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis.
    Expert Opin Ther Targets, 13(9): 1121-34. [Abstract] [Full-text]
51. CNS and lung metastasis of sebaceous epithelioma in a dog.
    Vet Dermatol, 20(4): 289-94. [Abstract] [Full-text]
52. Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma.
    J Clin Oncol, 27(23): 3861-7. [Abstract] [Full-text]
53. No evidence for WT1 involvement in a beta-catenin-independent activation of the Wnt signaling pathway in pituitary adenomas.
    Endocr Pathol, 20(3): 158-62. [Abstract] [Full-text]
54. IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas.
    Neuro Oncol, 11(4): 341-7. [Abstract] [Full-text]
55. Pseudoprogression in boron neutron capture therapy for malignant gliomas and meningiomas.
    Neuro Oncol, 11(4): 430-6. [Abstract] [Full-text]
56. Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas.
    Neuro Oncol, 11(4): 348-56. [Abstract] [Full-text]
57. Characterization and immunotherapeutic potential of gammadelta T-cells in patients with glioblastoma.
    Neuro Oncol, 11(4): 357-67. [Abstract] [Full-text]
58. Long-term control of disseminated pleomorphic xanthoastrocytoma with anaplastic features by means of stereotactic irradiation.
    Neuro Oncol, 11(4): 446-51. [Abstract] [Full-text]
59. The role of the membrane cytoskeleton cross-linker ezrin in medulloblastoma cells.
    Neuro Oncol, 11(4): 381-93. [Abstract] [Full-text]
60. Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2.
    Neuro Oncol, 11(4): 368-80. [Abstract] [Full-text]
61. Age-incidence patterns of primary CNS tumors in children, adolescents, and adults in England.
    Neuro Oncol, 11(4): 403-13. [Abstract] [Full-text]
62. Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors.
    Neuro Oncol, 11(4): 394-402. [Abstract] [Full-text]
63. Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic.
    Neuro Oncol, 11(4): 437-45. [Abstract] [Full-text]
64. The use of antiepileptic drugs in pediatric brain tumor patients.
    Pediatr Neurol, 41(3): 192-4. [Abstract] [Full-text]
65. Motexafin gadolinium: a novel radiosensitizer for brain tumors.
    Expert Opin Pharmacother, 10(13): 2171-80. [Abstract] [Full-text]
66. Effects of simulated microgravity on proliferation and chemosensitivity in malignant glioma cells.
    Neurosci Lett, 463(1): 54-9. [Abstract] [Full-text]
67. Lost in laterality: interpreting ''preferred side of the head during mobile phone use and risk of brain tumour'' associations.
    Scand J Public Health, 37(6): 664-7. [Abstract] [Full-text]
68. Correlative analysis of gene expression profile and prognosis in patients with gliomatosis cerebri.
    Cancer, 115(16): 3749-57. [Abstract] [Full-text]
69. Combined radio- and chemotherapy of brain tumours in adult patients.
    Clin Oncol (R Coll Radiol), 21(7): 515-24. [Abstract] [Full-text]
70. Glioblastoma in the elderly: the Memorial Sloan-Kettering Cancer Center Experience (1997-2007).
    Cancer, 115(16): 3758-66. [Abstract] [Full-text]
71. Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: comparison with MR perfusion imaging.
    AJNR Am J Neuroradiol, 30(7): 1402-8. [Abstract] [Full-text]
72. Delivery of temozolomide to the tumor bed via biodegradable gel matrices in a novel model of intracranial glioma with resection.
    J Neurooncol, 94(2): 203-12. [Abstract] [Full-text]
73. Decreased expression of NDRG1 in glioma is related to tumor progression and survival of patients.
    J Neurooncol, 94(2): 213-9. [Abstract] [Full-text]
74. Primary cerebral lymphomatoid granulomatosis: report of four cases and literature review.
    J Neurooncol, 94(2): 235-42. [Abstract] [Full-text]
75. Use of FDA approved methamphetamine to allow adjunctive use of methylnaltrexone to mediate core anti-growth factor signaling effects in glioblastoma.
    J Neurooncol, 94(2): 163-7. [Abstract] [Full-text]
76. Upregulation of LRIG1 suppresses malignant glioma cell growth by attenuating EGFR activity.
    J Neurooncol, 94(2): 183-94. [Abstract] [Full-text]
77. Pediatric brain tumors: mutations of two dioxygenases (hABH2 and hABH3) that directly repair alkylation damage.
    J Neurooncol, 94(2): 195-201. [Abstract] [Full-text]
78. Stromal cell-derived factor-1 expression in pituitary adenoma tissues and upregulation in hypoxia.
    J Neurooncol, 94(2): 173-81. [Abstract] [Full-text]
79. Clinicopathologic features of recurrent dysembryoplastic neuroepithelial tumor and rare malignant transformation: a report of 5 cases and review of the literature.
    J Neurooncol, 94(2): 283-92. [Abstract] [Full-text]
80. Aggression in a patient with primary brain tumor: ethical implications for best management.
    J Neurooncol, 94(2): 293-6. [Abstract] [Full-text]
81. The relationships between depression and brain tumors.
    J Neurooncol, 94(2): 153-61. [Abstract] [Full-text]
82. No association of (-131C-->G) variant of CHI3L1 gene with risk of glioblastoma and prognosis.
    J Neurooncol, 94(2): 169-72. [Abstract] [Full-text]
83. Two phase II trials of temozolomide with interferon-alpha2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme.
    Br J Cancer, 101(4): 615-20. [Abstract] [Full-text]
84. Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours.
    Br J Cancer, 101(4): 722-33. [Abstract] [Full-text]
85. Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up.
    Lancet Neurol, 8(9): 810-8. [Abstract] [Full-text]
86. Small-molecule multidrug resistance-associated protein 1 inhibitor reversan increases the therapeutic index of chemotherapy in mouse models of neuroblastoma.
    Cancer Res, 69(16): 6573-80. [Abstract] [Full-text]
87. Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols.
    Blood, 114(7): 1314-8. [Abstract] [Full-text]
88. Thrombin up-regulates vascular endothelial growth factor in experimental gliomas.
    Neurol Res, 31(7): 759-65. [Abstract] [Full-text]
89. Cerebral malignancy presenting with post stroke depression.
    Psychiatr Q, 80(3): 191-7. [Abstract] [Full-text]
90. Risk factors for brain relapse in HER2-positive metastatic breast cancer patients.
    Breast Cancer Res Treat, 117(2): 297-303. [Abstract] [Full-text]
91. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Neurosurgery, 65(3): 610-24; discussion 624. [Abstract] [Full-text]
92. Ki-67 in pituitary neoplasms: a review--part I.
    Neurosurgery, 65(3): 429-37; discussion 437. [Abstract] [Full-text]
93. ABCG2 is related with the grade of glioma and resistance to mitoxantone, a chemotherapeutic drug for glioma.
    J Cancer Res Clin Oncol, 135(10): 1369-76. [Abstract] [Full-text]
94. Nonfunctioning pituitary adenomas: the Oxford experience.
    Nat Rev Endocrinol, 5(9): 519-22. [Abstract] [Full-text]
95. Unexpected I-123 FP-CIT uptake in a brain tumor.
    Clin Nucl Med, 34(9): 608-9. [Abstract] [Full-text]
96. Intensely hypermetabolic extra-axial brainstem tumor in Erdheim-Chester disease.
    Clin Nucl Med, 34(9): 604-7. [Abstract] [Full-text]
97. Younger age is a good predictor of better executive function after surgery for pituitary adenoma in adults.
    J Int Neuropsychol Soc, 15(5): 803-6. [Abstract] [Full-text]
98. Radiosensitizing effects of temozolomide observed in vivo only in a subset of O6-methylguanine-DNA methyltransferase methylated glioblastoma multiforme xenografts.
    Int J Radiat Oncol Biol Phys, 75(1): 212-9. [Abstract] [Full-text]
99. Effects of concurrent topotecan and radiation on 6-month progression-free survival in the primary treatment of glioblastoma multiforme.
    Int J Radiat Oncol Biol Phys, 75(1): 164-9. [Abstract] [Full-text]
100. T1-weighted fluid-attenuated inversion recovery and T1-weighted fast spin-echo contrast-enhanced imaging: a comparison in 20 patients with brain lesions.
     J Med Imaging Radiat Oncol, 53(4): 366-72. [Abstract] [Full-text]
101. Brain angiogenesis in developmental and pathological processes: mechanism and therapeutic intervention in brain tumors.
     FEBS J, 276(17): 4653-64. [Abstract] [Full-text]
102. Prospective study of meat intake and dietary nitrates, nitrites, and nitrosamines and risk of adult glioma.
     Am J Clin Nutr, 90(3): 570-7. [Abstract] [Full-text]
103. Whole-brain radiotherapy with simultaneous integrated boost to multiple brain metastases using volumetric modulated arc therapy.
     Int J Radiat Oncol Biol Phys, 75(1): 253-9. [Abstract] [Full-text]
104. Tumorigenicity of cortical astrocyte cell line induced by the protease ADAM17.
     Cancer Sci, 100(9): 1597-604. [Abstract] [Full-text]
105. Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas.
     Int J Radiat Oncol Biol Phys, 75(1): 156-63. [Abstract] [Full-text]
106. Metastasis to pituitary adenoma: case report and review of the literature.
     Cen Eur Neurosurg, 70(3): 149-53. [Abstract] [Full-text]
107. Assessment of normal perisellar anatomy in 1.5 T T2-weighted MRI and comparison with the anatomic criteria defining cavernous sinus invasion of pituitary adenomas.
     Cen Eur Neurosurg, 70(3): 130-6. [Abstract] [Full-text]
108. Apoptotic proteins and markers of differentiation in childhood pineal parenchymal tumors: relationships and prognostic value.
     Cen Eur Neurosurg, 70(3): 115-24. [Abstract] [Full-text]
109. Data assimilation using a gradient descent method for estimation of intraoperative brain deformation.
     Med Image Anal, 13(5): 744-56. [Abstract] [Full-text]
110. Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.
     Clin Neurol Neurosurg, 111(8): 679-82. [Abstract] [Full-text]
111. Coexistence of cerebral aneurysm and meningioma--pure accident?
     Clin Neurol Neurosurg, 111(8): 647-54. [Abstract] [Full-text]
112. Phase II evaluation of intravenous vinorelbine (Navelbine) in recurrent or refractory pediatric malignancies: a Children's Oncology Group study.
     Pediatr Blood Cancer, 53(4): 590-3. [Abstract] [Full-text]
113. Nutritional problems in children treated for medulloblastoma: implications for enteral nutrition support.
     Pediatr Blood Cancer, 53(4): 570-5. [Abstract] [Full-text]
114. Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas.
     J Neurooncol, 94(3): 299-312. [Abstract] [Full-text]
115. Pineal gland tumors: experience from the SEER database.
     J Neurooncol, 94(3): 351-8. [Abstract] [Full-text]
116. 'Putting our heads together': insights into genomic conservation between human and canine intracranial tumors.
     J Neurooncol, 94(3): 333-49. [Abstract] [Full-text]
117. Quantification of dispersion of Gd-DTPA from the initial area of enhancement into the peritumoral zone of edema in brain tumors.
     J Neurooncol, 94(3): 399-408. [Abstract] [Full-text]
118. Gamma Knife radiosurgery after radiation therapy as an adjunctive treatment for glioblastoma.
     J Neurooncol, 94(3): 409-18. [Abstract] [Full-text]
119. Evolution of neurological impairment in pediatric infratentorial ependymoma patients.
     J Neurooncol, 94(3): 391-8. [Abstract] [Full-text]
120. Primary anaplastic pleomorphic xanthoastrocytoma with widespread neuroaxis dissemination at diagnosis--a pediatric case report and review of the literature.
     J Neurooncol, 94(3): 431-7. [Abstract] [Full-text]
121. CTNNB1 (beta-catenin) mutation is rare in brain tumours but involved as a sporadic event in a brain metastasis.
     Acta Neurochir (Wien), 151(9): 1107-11. [Abstract] [Full-text]
122. Metastatic retinoblastoma: single institution experience over two decades.
     Br J Ophthalmol, 93(9): 1163-6. [Abstract] [Full-text]
123. Astrocytoma derived short-term cell cultures retain molecular signatures characteristic of the tumour in situ.
     Exp Cell Res, 315(16): 2835-46. [Abstract] [Full-text]
124. Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma.
     Ann Oncol, 20(9): 1596-603. [Abstract] [Full-text]
125. Primary T-cell lymphoma of the retina and cerebellum: immunophenotypic and gene rearrangement confirmation.
     Am J Ophthalmol, 148(3): 350-60. [Abstract] [Full-text]
126. Detection of tumour invasion into the pyramidal tract in glioma patients with sensorimotor deficits by correlation of (18)F-fluoroethyl-L: -tyrosine PET and magnetic resonance diffusion tensor imaging.
     Acta Neurochir (Wien), 151(9): 1061-9. [Abstract] [Full-text]
127. A comparison between surgical resection in combination with WBRT or hypofractionated stereotactic irradiation in the treatment of solitary brain metastases.
     Acta Neurochir (Wien), 151(9): 1053-9. [Abstract] [Full-text]
128. Manifestation, management and outcome of subclinical pituitary adenoma apoplexy.
     J Clin Neurosci, 16(10): 1273-5. [Abstract] [Full-text]
129. Post-traumatic intradiploic leptomeningeal cyst of the posterior fossa in an adult.
     J Clin Neurosci, 16(10): 1367-9. [Abstract] [Full-text]
130. Expression profiling of ependymomas unravels localization and tumor grade-specific tumorigenesis.
     Cancer, 115(17): 3955-68. [Abstract] [Full-text]
131. Low-grade gliomas in older patients: long-term follow-up from Mayo Clinic.
     Cancer, 115(17): 3969-78. [Abstract] [Full-text]
132. In vitro and in vivo optimization of an anti-glioma modality based on synchrotron X-ray photoactivation of platinated drugs.
     Radiat Res, 172(3): 348-58. [Abstract] [Full-text]
133. BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases.
     Oncogene, 28(34): 3022-32. [Abstract] [Full-text]
134. Efficacy of anti-epileptic drugs in patients with gliomas and seizures.
     J Neurol, 256(9): 1519-26. [Abstract] [Full-text]
135. Brain metastases in patients with pelvic or abdominal malignancy do not prevail in the posterior fossa: a retrospective study.
     J Neurol, 256(9): 1485-7. [Abstract] [Full-text]
136. What are the experiences of the child with a brain tumour and their parents?
     Eur J Oncol Nurs, 13(4): 255-61. [Abstract] [Full-text]
137. Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial.
     J Clin Oncol, 27(25): 4155-61. [Abstract] [Full-text]
138. Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.
     J Clin Oncol, 27(25): 4150-4. [Abstract] [Full-text]
139. Glioma-induced remodeling of the neurovascular unit.
     Brain Res, 1288: 125-34. [Abstract] [Full-text]
140. Induction of oligodendrogenesis in glioblastoma-initiating cells by IFN-mediated activation of STAT3 signaling.
     Cancer Lett, 284(1): 71-9. [Abstract] [Full-text]

© 2004-2010 Brain Tumors Research Today. All Rights Reserved.